GSA Capital Partners’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-51,026
Closed -$1.15M 2072
2025
Q1
$1.15M Sell
51,026
-9,048
-15% -$210K 0.1% 280
2024
Q4
$1.17M Buy
60,074
+9,099
+18% +$180K 0.09% 302
2024
Q3
$928K Buy
50,975
+35,439
+228% +$676K 0.07% 515
2024
Q2
$270K Buy
+15,536
New +$275K 0.02% 1326
2022
Q4
Sell
-9,531
Closed -$325K 1804
2022
Q3
$325K Buy
+9,531
New +$352K 0.04% 875

Other funds holding PRVA

GSA Capital Partners's PRVA Position: Q2 2025 in Review

GSA Capital Partners sold out of Privia Health (PRVA) in Q2 2025, closing a stake of 51,026 shares — an estimated $1.15M sold.

GSA Capital Partners first reported a position in PRVA in Q3 2022 and held it in 5 quarters. The position peaked at $1.17M in Q4 2024. 280 funds tracked by Wall St. Rank hold PRVA as of Q2 2025.

  • GSA Capital Partners reported no remaining Privia Health position as of Q2 2025 after selling out during the quarter.
  • GSA Capital Partners sold 51,026 Privia Health shares in Q2 2025, an estimated $1.15M.
  • GSA Capital Partners first reported a position in Privia Health in Q3 2022 and held it in 5 quarters.
  • GSA Capital Partners's Privia Health position peaked at $1.17M in Q4 2024.
  • 280 funds tracked by Wall St. Rank held Privia Health as of Q2 2025.

Based on GSA Capital Partners's 13F filing for Q2 2025, filed 22 Jul 2025.